Global Hip Dysplasia Registry

Launched by UNIVERSITY OF BRITISH COLUMBIA · Oct 3, 2019

Keywords

ClinConnect Summary

The Global Hip Dysplasia Registry is a clinical trial aimed at studying developmental dysplasia of the hip (DDH), a common condition in infants and young children where the hip joint does not form properly. This can lead to instability or dislocation of the hip, which can affect a child's ability to walk and develop normally. The goal of this registry is to gather information and data from children diagnosed with DDH so that doctors can identify the best ways to treat and manage this condition, ultimately improving outcomes for children around the world.

To be eligible for this trial, children must be between the ages of 0 and 10 years and either have risk factors for DDH or have already been diagnosed with it through imaging tests like ultrasounds or X-rays. Unfortunately, children with certain other medical conditions, or those over 10 years old when diagnosed, cannot participate. Parents who enroll their children in this study can expect to contribute information about their child's condition, which will help researchers understand DDH better and improve future treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Between the ages of 0 and 10 years at time of initial diagnosis
• • Referred for DDH screening due to specific risk factors OR diagnosed with DDH
• • Diagnosis confirmed with appropriate ultrasonographic or radiographic imaging
• Exclusion Criteria:
• • Known or suspected neuromuscular, collagen, chromosomal or lower extremity congenital anomalies
• • Teratologic hip dislocation (syndromic-associated dislocations)
• • Over 10 years of age at initial diagnosis
• • Received prior treatment for DDH without appropriate imaging or documentation